Ric Blake is disheartened but hopeful
By Marjory Sherman
Eagle-Tribune Writer
A drawn and tired Ric Blake headed back to the National Institutes of Health
feeling more exhausted than he'd ever expected.
No moment in all the months since The Eagle-Tribune began following Blake's
journey with terminal thyroid cancer in January was more disheartening. In
the four weeks since he finished chemotherapy and external beam radiation,
he had become sicker, rather than stronger. This was far from the way he
thought it would go.
"I'm feeling like I'm never going to get well. That's how I'm feeling,''
said Blake before he left. "It's a failure of faith, I think, because I
can't even get a good night's sleep. I haven't had a day when I felt well in
so long, I can't even remember what it's like. I'm tired. I'm sick of being
sick.''
Just when he finally started to recover from the side effects of Taxol and
radiation, Blake began to feel a different kind of sick: nauseous and
exhausted. He dropped 22 pounds in three weeks, had frequent bouts of
diarrhea, spiked a fever from 99 to 101 frequently. The weight loss and
other symptoms were deeply disturbing.
"It's like the last straw,'' he said. "You should see my face. It's so sad.
It's absolutely collapsing like a clay face. It's just falling apart.''
So it was with a sense of dispiritedness that Ric and Diane Blake left their
home in Londonderry, N.H., a month ago to drive to the campus of the
National Institutes of Health in Bethesda, Md, that houses the national
government's arm of research medicine.
The Blakes had originally planned to fly to N.I.H., but in the wake of the
Sept. 11 terrorist attacks, Reagan National Airport in Washington, D.C., was
closed. So the Blakes drove to N.I.H., which was itself locked up tight,
with intense security all around. When they pulled into the parking lot,
security guards not only searched them, but also looked under the carriage
of the car for weapons.
Once Blake was settled in a patient room on 8 West in the clinical unit at
N.I.H., there were hints, small signs, of good news. Initial tests showed
that his tumor marker, thyroglobulin, had dropped 19 points, from 86 in June
to 67 this week.
On his third day there, a doctor removed the feeding tube that has been
hanging from his belly for months, a tube that was an insult to his sense of
self and that initially caused a painful infection. The tube served its
purpose, however, allowing him for weeks to bypass his painfully swollen
windpipe as needed with syringes full of nourishment and pain medication.
His biggest boost in the week before he headed to N.I.H. was that his voice
returned, after weeks of being reduced to a whisper from swelling that comes
along with radiation treatment. For weeks, his once-resonant voice, a beacon
of hope and courage to many readers who are following his journey with
advanced thyroid cancer, nearly disappeared. He could not talk on the
telephone and felt so sick that he did not write e-mails, either. Now, in
the days before heading to N.I.H., it had returned.
By Thursday morning, the Blakes were ready for "The'' meeting at 11 a.m.
with Blake's physician Dr. Nicholas J. Sarlis.
The news was heartening, though not as positive as the Blakes might have
hoped. The tumors on his trachea and larynx are still there, but the largest
one has shrunk by 1 millimeter, the ultrasound and CT contrast studies show.
"Ric's disease has been stable. We cannot find any significant reduction in
his disease despite the fact that he took this semi-experimental treatment
with the Taxol and radiation,'' the doctor said.
Sarlis is carefully planning his next step in attacking the cancer. It could
ultimately put the surgery option back on the table, meaning that, with
radiation and chemotherapy, a cancer once called inoperable would be
rendered operable.
The final analysis of whether the treatment worked will not be known until
Blake returns to N.I.H. on Jan 7 for a Positron Emission Tomography (PET)
scan in addition to the Magnetic Resonance Imaging (MRI) and Computed
Tomography (CT) scans. PET scans are quite accurate, but are not reliable
until months after radiation treatment, when all swelling has disappeared
and the full effects of chemotherapy take hold.
Sarlis has two hopes for Blake, come January.
"What we're hoping to see, in the best-case scenario, is that his disease
would have completely disappeared. More realistically, what I would hope to
see is a significant reduction in the size and volume of his disease,'' he
said.
Enough reduction in the disease in Blake's windpipe could prompt Sarlis to
recommend surgery. Blake's case would mark only the second time in the
doctor's experience where he attempted to make a once-inoperable thyroid
cancer operable by killing off enough of it with chemotherapy and radiation.
The same treatment works sometimes in non small cell lung cancers with good
results, he said.
All of the talk of future surgery is jumping far ahead of the game for a
pragmatist like Blake, a man who lives in the moment, both by nature and
because of his illness.
Blake was surprised that early tests did not show significant improvement in
his disease, but he is trying to maintain a positive outlook.
"I feel all right. It's about what I expected,'' he said. "Only 1 millimeter
smaller is not very much smaller. I wanted them to be a lot smaller. But the
thyroglobulin did not rise.''
Now back at home again, Blake is feeling a bit better, returning to his
garden in short stints and once again playing "Risk" on his computer.
He knows that the longer the bulky tumors sit in his neck, the greater the
chance they will mutate into an aggressive form of cancer cell that is
undifferentiated, called "anaplastic.'' Once that happens, life expectancy
is very short, maybe six months. He knows that the surgery would help avoid
that, but he knows there are dangers involved too.
Meanwhile, the bigger mystery that followed him down to NIH has been solved.
The exhaustion and illness that struck in the weeks after the treatment was
due to colitis caused by a bacteria that strikes people who have taken a lot
of antibiotics.
As his week at N.I.H. drew to a close, there was one final sobering moment.
A woman at the Thyroid Cancer Survivors Conference he attended at the end of
his week in Bethesda announced that her cancer is anaplastic, and she has
six months to live. He spoke to her at length afterwards.
Even more difficult for Blake was returning to his advanced cancer support
group at Lowell General Hospital last Tuesday to learn that fellow cancer
survivor Elaine, a former nurse with whom he had shared much there, died
Monday night. Elaine was the fifth of the six original members of the
support group to die. The group has been in existence since December and now
Blake is the only surviving member.
"The magic of the group is you get to know people in ways their family does
not know them. When you have that level of intimacy with people, you have a
very different relationship. And they're all gone. That's hard,'' he said.
Yet despite the loss of friends, despite his own exhaustion and weight loss,
Blake continues to open his life to others so that the message of living
well until the end rings out for people in the Merrimack Valley.